Global Health Ltd - Stock Valuation and Financial Performance

BSE: 543654 | NSE: MEDANTA | Hospital & Healthcare Services | Mid Cap

Global Health Share Price

1,400.25 -24.60 -1.73%
as on 12-Apr'24 16:59

DeciZen - make an informed investing decision on Global Health

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Global Health stock performance -

mw4me loader
P/E Ratio (SA):
107.36
Market Cap:
37,534.7 Cr.
52-wk low:
483.1
52-wk high:
1,513.8

Is Global Health Ltd an attractive stock to invest in?

1. Is Global Health Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Global Health Ltd is a good quality company.

2. Is Global Health Ltd undervalued or overvalued?

The key valuation ratios of Global Health Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Global Health Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Global Health Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Global Health:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Global Health Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 15.4%17.4%17.4%5.7%4.2%5.6%8.6%5.2%14.3%12.9%-
Value Creation
Index
0.40.50.5-0.5-0.6-0.5-0.2-0.50.00.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1,0701,1941,3821,2771,3431,4411,4721,2271,7651,9592,189
Sales YoY Gr.-11.6%15.7%-7.6%5.2%7.3%2.2%-16.6%43.8%11%-
Adj EPS 5.56.27.22.31.62.64.12.38.69.913
YoY Gr.-12.2%17.3%-68.4%-32.3%69.7%57.4%-44.7%276.9%14.5%-
BVPS (₹) 29.635.642.544.44649.954.457.268.592.6102.7
Adj Net
Profit
13315017655.537.564.710256.8219265350
Cash Flow from Ops. 25221422812480.1152193201235431-
Debt/CF from Ops. 0.50.20.61.52.10.90.10.10.50.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7%7.8%10%11%
Adj EPS 6.7%44.8%33.6%14.5%
BVPS13.5%15%19.4%35.2%
Share Price - - - 186.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
20.618.51853.25.17.53.913.612.513.3
Op. Profit
Mgn %
20.42222.1109.710.114.914.121.620.921.2
Net Profit
Mgn %
12.512.512.74.32.84.56.94.612.413.516
Debt to
Equity
0.20.10.10.20.20.1000.10-
Working Cap
Days
46404254657380154158168108
Cash Conv.
Cycle
-589-14-9-3595109873

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 13.30%

Net Profit is growing at healthy rate in last 3 years 33.63%

Sales growth is good in last 4 quarters at 17.42%

Sales growth has been subdued in last 3 years 10.00%

Latest Financials - Global Health Ltd.

Standalone Consolidated
TTM EPS (₹) 13 16.8
TTM Sales (₹ Cr.) 2,189 3,153
BVPS (₹.) 102.7 103.5
Reserves (₹ Cr.) 2,703 2,724
P/BV 13.62 13.51
PE 107.36 83.06
From the Market
52 Week Low / High (₹) 483.05 / 1513.75
All Time Low / High (₹) 391.05 / 1513.75
Market Cap (₹ Cr.) 37,535
Equity (₹ Cr.) 53.7
Face Value (₹) 2
Industry PE 87.4

Management X-Ray of Global Health:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Global Health

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales1,0701,1941,3821,2771,3431,4411,4721,2271,7651,959
Operating Expenses 8519311,0771,1511,2131,2971,2541,0541,3841,552
Manufacturing Costs0505593139182170206294342
Material Costs0322363285313325314298441459
Employee Cost 0422472519527541522416495532
Other Costs 851138187253234250248135155219
Operating Profit 218263305127130144219173381408
Operating Profit Margin (%) 20.4%22.0%22.1%9.9%9.7%10.0%14.8%14.1%21.6%20.8%
Other Income 34364567496544283562
Interest 091423282133293332
Depreciation 47626981869199888786
Exceptional Items 0000000000
Profit Before Tax 20522926890649713184296352
Tax 72799235273428277788
Profit After Tax 13315017655376310357219263
PAT Margin (%) 12.5%12.5%12.7%4.3%2.8%4.4%7.0%4.7%12.4%13.4%
Adjusted EPS (₹)5.76.37.32.31.52.64.22.38.69.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 7318811,0571,1091,1481,2581,3741,4511,7342,484
Share Capital 80808181818282825154
Reserves 6518019761,0281,0671,1771,2921,3691,6842,430
Minority Interest0000000000
Debt694012416214811518198958
Long Term Debt694011313212311518198958
Short Term Debt0011302500000
Trade Payables838392104106126118109103142
Others Liabilities 2412142232883072594978389271,070
Total Liabilities 1,1231,2181,4961,6641,7091,7582,0082,4182,8543,754

Fixed Assets

Gross Block9149801,2131,1261,1671,1981,3501,3541,4101,472
Accumulated Depreciation170231300154239329421502583663
Net Fixed Assets744749913972928869929851827810
CWIP 10231187534675
Investments 991400356501626734765
Inventories20252821232332324042
Trade Receivables385375107152164148130173173
Cash Equivalents 2343033714692532402192554411,145
Others Assets68558486346101175521632744
Total Assets 1,1231,2181,4961,6641,7091,7582,0082,4182,8543,754

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 25221422812480152193201235431
PBT 20522926890649713184296352
Adjustment 61637610712210512210510083
Changes in Working Capital 25-24-18-14-523-426-6996
Tax Paid -39-54-97-58-53-67-56-15-91-101
Cash Flow From Investing Activity -65-126-245-112-46-104-45-250-313-257
Capex -40-76-156-90-49-29-17-23-64-115
Net Investments 000-48-233696-117-162-145
Others -26-50-892625-111-124-111-873
Cash Flow From Financing Activity -181-87-7-6-36-49-56-3798404
Net Proceeds from Shares 33110010038479
Net Proceeds from Borrowing 0000-8-6-16098-34
Interest Paid -28-9-11-17-23-18-23-21-24-25
Dividend Paid 0000000000
Others -186-79411-5-25-16-15-14-16
Net Cash Flow 60-246-2-192-8620577
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)21.1319.3318.765.243.415.3884.1513.8812.48
ROCE (%)23.6226.5326.398.896.788.2911.37.6919.5117.23
Asset Turnover Ratio0.961.021.020.810.80.830.780.550.670.59
PAT to CFO Conversion(x)1.891.431.32.252.162.411.873.531.071.64
Working Capital Days
Receivable Days15141726354039413132
Inventory Days77776671078
Payable Days094881261231311421398898

Global Health Ltd Stock News

Global Health Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Global Health on 12-Apr-2024 16:59 is ₹1,400.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Apr-2024 16:59 the market cap of Global Health stood at ₹37,534.7.
The latest P/E ratio of Global Health as of 12-Apr-2024 16:59 is 107.4.
The latest P/B ratio of Global Health as of 12-Apr-2024 16:59 is 13.62.
The 52-week high of Global Health is ₹1,513.8 and the 52-week low is ₹483.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Global Health is ₹2,189 ( Cr.) .

About Global Health Ltd

The company was incorporated as ‘Global Health Private Limited’ on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the Registrar of Companies, Delhi and Haryana at Delhi (RoC). The company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by its Shareholders at the EGM held on July 31, 2021 and consequently, the name of the Company was changed to ‘Global Health Limited’ and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.

The company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Under the “Medanta” brand, the company has a network of many hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction. The company strives to deliver advanced healthcare by establishing institutes of excellence that integrate medical care, teaching and research all while providing affordable medical services to patients.

Business area of the company

Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Key awards, accreditations, certifications and recognitions

Accreditations

  • 2011: 1st National Accreditation Board for Hospitals and Healthcare Providers (“NABH”) accreditation for the hospital at Gurugram
  • 2011: 1st National Accreditation Board for Testing and Calibration Laboratories accreditation for the hospital at Gurugram.
  • 2013: 1st Joint Commission International (JCI) accreditation for the hospital at Gurugram
  • 2014: 1st NABH (blood bank) accreditation for the hospital at Gurugram.
  • 2016: 1st NABH accreditation for the hospital at Indore.
  • 2018: 1st NABH accreditation for the hospital at Ranchi.
  • 2020: 1st NABH accreditation for the Medanta Institutional Ethics Committee at the hospital at Gurugram.
  • 2022: 1st NABH accreditation for the hospital at Lucknow.

Awards

  • 2020: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2021: Hospital at Gurugram featured in the top 200 global hospitals by Newsweek.
  • 2021: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2021: Hospital at Gurugram featured in the list of world’s best specialised hospitals for cardiology by Newsweek.
  • 2021: Hospital at Gurugram awarded ‘Best Multi-Speciality Hospital – National’ at ‘The Economic Times Healthcare Awards, 2021’.
  • 2021: Hospital at Gurugram ranked as the best multi-specialty private hospital in North India by The Week.
  • 2021: Hospital at Gurugram was ranked first for emergency, neurology, gynaecology, and ranked second for cardiology, gastroenterology, nephrology, oncology and urology by The Times of India’s Critical Care Study 2021.
  • 2022: Hospital at Gurguram featured in the list of world’s best specialised hospitals for cardiology and neurology by Newsweek.
  • 2022: Hospital at Gurugram featured in the top 250 global hospitals by Newsweek.
  • 2022: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2022: Hospital at Gurugram ranked as the best multi-speciality private hospital in North India and the second best private hospital in India as per Best All India Multi Speciality Hospital Ranking 2022 by Outlook and NEB Research.

Major Events:

  • 2009: Establishment and commencement of operations of Medanta – the Medicity Hospital at Gurugram.
  • 2010: Leased premises for clinic at the Indira Gandhi International Airport, New Delhi.
  • 2010: Leased premises for clinic at Defence Colony, New Delhi.
  • 2013: Anant Investments (i.e., Investor Selling Shareholder) invested in Company.
  • 2013: Leased premises for clinic at DLF Cybercity.
  • 2014: Entered into a 27-year lease for hospital at Indore.
  • 2015: Dunearn Investments (Mauritius) Pte Ltd invested in Company.
  • 2015: Entered into a 15-year lease for hospital at Ranchi.
  • 2015: GHPPL entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.
  • 2016: Entered into a 90-year lease for a proposed hospital at Noida.
  • 2019: Commencement of operations of new hospital at Lucknow by MHPL.
  • 2020: Gurugram hospital outpatient department pharmacy taken in-house.
  • 2020: Launch of outpatient department at hospital at Patna by GHPPL.
  • 2021: Lucknow hospital outpatient department pharmacy taken in-house.
  • 2021: Indore hospital outpatient department pharmacy taken in-house.
  • 2021: Ranchi hospital outpatient department pharmacy taken in-house.
  • 2021: Launch of outpatient department pharmacy at south Delhi clinic.
  • 2022: Patna hospital’s inpatient department facility commenced operations.
  • 2022: Launch of Patna hospital outpatient department pharmacy.
  • 2022: Leased premises for clinic at Subhash Chowk.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.